Through an intimate set of collaborative interactions with three other laboratories working in invertebrate and mammalian systems, we have developed a genome-wide approach to define the conserved functional "interactome" for Survival of Motor Neurons (SMN), the highly conserved gene family causal to over 95% of Spinal Muscular Atrophy (SMA), one of the most common degenerative motor neuron diseases in humans. Through recent studies, Drosophila has emerged as a promising genetic model for Smn with the key hallmarks of human SMA, from failure of neuromuscular junctions to the degeneration of neurons and muscles. Despite an emphasis in the SMA field to focus on mouse models, the innovative use of invertebrate species to understand SMN biology and define conserved and potentially druggable effector pathways was recently supported by a patient advocacy group (the SMA Foundation). Our analysis of Smn modifier mutations and compounds/factors derived from chemical and genetic screens in Drosophila, C. elegans and human cells has identified several strong and conserved candidate pathways, including the Bone-Morphogenic Protein (BMP)-family signaling pathway known to control neuromuscular junction (NMJ) development in flies. Modulation of this BMP retrograde synaptic signaling pathway alone can potently attenuate key NMJ phenotypes of Smn loss in Drosophila. Therefore, in addition to completion of our secondary screens to define the Smn functional network, we here propose parallel levels of analysis to determine precisely how loss of Smn disrupts BMP signaling, and to what extent manipulation of the highly conserved elements in the BMP pathway can reverse the defects in neuromuscular structure and function resulting from reduced Smn activity. We will apply a combination of genetic, biochemical and developmental analyses to answer these questions, as we continue to identify the other conserved effectors downstream of SMN.

National Institute of Health (NIH)
Research Program Projects (P01)
Project #
Application #
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Harvard Medical School
United States
Zip Code
Amaral, Andreia J; Brito, Francisco F; Chobanyan, Tamar et al. (2014) Quality assessment and control of tissue specific RNA-seq libraries of Drosophila transgenic RNAi models. Front Genet 5:43
Kwon, Deborah Y; Dimitriadi, Maria; Terzic, Barbara et al. (2013) The E3 ubiquitin ligase mind bomb 1 ubiquitinates and promotes the degradation of survival of motor neuron protein. Mol Biol Cell 24:1863-71
Berke, Brett; Wittnam, Jessica; McNeill, Elizabeth et al. (2013) Retrograde BMP signaling at the synapse: a permissive signal for synapse maturation and activity-dependent plasticity. J Neurosci 33:17937-50
Yang, Yin M; Gupta, Shailesh K; Kim, Kevin J et al. (2013) A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. Cell Stem Cell 12:713-26
Dimitriadi, Maria; Kye, Min Jeong; Kalloo, Geetika et al. (2013) The neuroprotective drug riluzole acts via small conductance Ca2+-activated K+ channels to ameliorate defects in spinal muscular atrophy models. J Neurosci 33:6557-62
Ding, Qiurong; Lee, Youn-Kyoung; Schaefer, Esperance A K et al. (2013) A TALEN genome-editing system for generating human stem cell-based disease models. Cell Stem Cell 12:238-51
Makhortova, Nina R; Hayhurst, Monica; Cerqueira, Antonio et al. (2011) A screen for regulators of survival of motor neuron protein levels. Nat Chem Biol 7:544-52